Supply Issues Becton Dickinson UK Ltd 1ml Luer Lock Hypodermic Syringe FWC121 (ICN 2963)

• The supply issue with 1ml Luer Lock Hypodermic Syringe products from Becton Dickinson is continuing.
• FWC121 is no longer subject to Protect Demand Management and is now suspended and unavailable to order.
• One product code remains affected in total.
• Potential indirect alternative products are available to order through our online catalogue.
• See our Downloads ▼ section to access the product listing for further information on the affected product code and potential alternatives.
• We will continue to review the stock to minimise further disruption and will update this ICN as soon as we have further information.
• The supply issue is still anticipated to be resolved by 4 July 2025.

Change:

• The supplier Becton Dickinson UK Ltd has informed us of a supply issue with its 1ml Luer Lock Hypodermic Syringe products.
• One product code is affected:
  • FWC121 – Hypodermic Syringe 1ml Luer Lock 3 Piece Concentric Clear Sterile.
• The supply issue is due to increased demand and lead times.
• Due to this supply issue this product is now being threshold managed as it is subject to Protect Demand Management.

Impact:

• FWC121 is available to order through NHS Supply Chain. However, trusts are allocated a maximum daily quantity or “threshold” to ensure fair supply of available stock across the NHS.
• Potential indirect alternative products are available to order through our online catalogue.
• See our Downloads ▼ section to access the product listing for further information on the affected product code and potential alternatives.
• The supply issue is anticipated to be resolved by 4 July 2025.

Next Steps:              

• Customers are advised to log into our website to view the product listing for further information on the affected product code and potential alternatives and to view the product code currently subject to Protect Demand Management.
• The continuing supply issue is being monitored in conjunction with the supplier and we will continue to review the stock situation to minimise further disruption and update this ICN with the latest information as it becomes available.
• However, as this is currently a disrupted market and supply is subject to rapid change, the alternatives offered may also be experiencing temporary supply issues and therefore, customers may need to consider clinically reviewing all additional alternatives provided.
• If you have any further questions, please contact your local NHS Supply Chain Customer Services Advisor.

Please note that due to the clinical nature of these alternative products, we advise you to consult your own clinical experts to ensure suitability for your organisations use of these products.